Product Description

This continuing medical education article is designed to refresh one’s knowledge on breast reduction while placing emphasis on clinical out- comes. It reviews the relevant anatomy, techniques, and published literature on outcomes, including those that are patient-reported. Photographic representations of most techniques are shown, in addition to supplemental digital video content, to demonstrate each technique. This is designed to be an overview, and the reader should appreciate that no one technique is “right,” and the technique used should be selected with patient factors and desired outcomes in mind.

Learning Objectives:
After studying this article, the participant should be able to:

1. Understand the relevant anatomy involved in breast reduction.
2. Under- stand the different breast reduction techniques and their indications.
3. Appreciate the outcomes of these techniques as they pertain to clinical outcomes

Authors: Shannon M Colohan, MD, MSc; Benjamin B Massenburg, MD; Alexander J Gougoutas, MD

Plastic and Reconstruction Surgery® Editors:
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editors: Donald H. Lalonde, MD; John Y S Kim, MD

Patient Safety Credit: 0.5
Media: Article, Video
Publish Date: 09/1/2020
Expiration Date: 09/1/2023
Estimated time to complete this course: 1.0 hour
Minimum Post-test Score to Claim Credit: 80%

Directly provided by the American Society of Plastic Surgeons (ASPS)

Accreditation Statement
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ASPS designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Disclosures:
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. Dr. Kim is a partner, Surgical Innovation Associates; Shareholder, Surgical Innovation Associates ($100,001-$200,000); Shareholder, Edge Surgical ($50,001-$100,000); Research funding, Allergan for "Breast Implants and Immune Modulation: Does implant placement promote a lasting systemic immune response capable of recognizing breast tumor associated antigens?" (Completed). None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

For medical disclaimer, privacy policy, and system requirements click here. 

Product Code: 30151